Lactate was implicated in the activation of hepatic stellate cells (HSCs). However, the mechanism by which lactate exerts its effect remains elusive. Using RNA-seq and CUT&Tag chromatin profiling, we found that induction of hexokinase 2 (HK2) expression in activated HSCs is required for induced gene expression by histone lactylation but not histone acetylation. Inhibiting histone lactylation by Hk2 deletion or pharmacological inhibition of lactate production diminishes HSC activation, whereas exogenous lactate but not acetate supplementation rescues the activation phenotype. Thus, lactate produced by activated HSCs determines the HSC fate via histone lactylation. We found that histone acetylation competes with histone lactylation, which could explain why class I HDAC (histone deacetylase) inhibitors impede HSC activation. Finally, HSC-specific or systemic deletion of HK2 inhibits HSC activation and liver fibrosis in vivo. Therefore, we provide evidence that HK2 may be an effective therapeutic target for liver fibrosis.
Pubmed ID: 37463576 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets IgG
View all literature mentionsThis polyclonal secondary targets IgG
View all literature mentionsThis isotype control targets not applicable
View all literature mentionsThis isotype control targets not applicable
View all literature mentionsThis monoclonal targets cells that have bromodeoxyuridine incorporated in their DNA
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets IgG (H+L)
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis monoclonal targets Pyruvate Dehydrogenase E1-alpha subunit antibody [8D10E6 ]
View all literature mentionsThis unknown targets PDHA1;PDHA2
View all literature mentionsThis monoclonal targets Histone H3
View all literature mentionsThis polyclonal targets Histone H3
View all literature mentionsThis polyclonal targets Histone H3 (acetyl K18) antibody - ChIP Grade
View all literature mentionsThis polyclonal targets Acetylated-Lysine
View all literature mentionsThis recombinant monoclonal targets Lactyl-Histone H3 (Lys18)
View all literature mentionsThis polyclonal targets lactyllysine
View all literature mentionsThis monoclonal targets beta-Actin
View all literature mentionsThis monoclonal targets slightly modified β-cytoplasmic actin N-terminal peptide, Ac-Asp-Asp-Asp-Ile-Ala-Ala-Leu-Val-Ile-Asp-Asn-Gly-Ser-Gly-Lys, conjugated to KLH
View all literature mentionsThis monoclonal targets COL1A1
View all literature mentionsThis monoclonal targets Actin, alpha, Smooth Muscle
View all literature mentionsThis monoclonal targets HK1
View all literature mentionsThis polyclonal targets Hexokinase 2
View all literature mentionsThis monoclonal targets Hexokinase II
View all literature mentions